Mesh.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Mesh.i » - entrée « Real-Time Polymerase Chain Reaction »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Reactive Oxygen Species < Real-Time Polymerase Chain Reaction < Receptor Activator of Nuclear Factor-kappa B  Facettes :

List of bibliographic references indexed by Real-Time Polymerase Chain Reaction

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
001212 (2018) Sung Soo Ahn [Corée du Sud] ; Seung Min Jung [Corée du Sud] ; Jason Jungsik Song [Corée du Sud] ; Yong Beom Park [Corée du Sud] ; Jun Yong Park [Corée du Sud] ; Sang Won Lee [Corée du Sud]Safety of Tocilizumab in Rheumatoid Arthritis Patients with Resolved Hepatitis B Virus Infection: Data from Real-World Experience.
001606 (2017) Patricia Ruiz-Lim N [Espagne] ; Rafaela Ortega [Espagne] ; Ivan Arias De La Rosa [Espagne] ; Maria Del Carmen Abalos-Aguilera [Espagne] ; Carlos Perez-Sanchez [Espagne] ; Yolanda Jimenez-Gomez [Espagne] ; Esther Peralbo-Santaella [Espagne] ; Pilar Font [Espagne] ; Desiree Ruiz-Vilches [Espagne] ; Gustavo Ferrin [Espagne] ; Eduardo Collantes-Estevez [Espagne] ; Alejandro Escudero-Contreras [Espagne] ; Chary L Pez-Pedrera [Espagne] ; Nuria Barbarroja [Espagne]Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation.
001759 (2017) Nathalie Balandraud [France] ; Gaetan Texier [France] ; Emmanuel Massy [France] ; Olivier Muis-Pistor [France] ; Marielle Martin [France] ; Isabelle Auger [France] ; Marie-Caroline Guzian [France] ; Sandrine Guis [France] ; Thao Pham [France] ; Jean Roudier [France]Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study
001A13 (2016) A Alicia Koblansky [États-Unis] ; Agnieszka D. Truax [États-Unis] ; Rongrong Liu [République populaire de Chine] ; Stephanie A. Montgomery [États-Unis] ; Shengli Ding [États-Unis] ; Justin E. Wilson [États-Unis] ; W June Brickey [États-Unis] ; Marcus Mühlbauer [États-Unis] ; Rita-Marie T. Mcfadden [États-Unis] ; Peizhen Hu [République populaire de Chine] ; Zengshan Li [République populaire de Chine] ; Christian Jobin [États-Unis] ; Pauline Kay Lund [États-Unis] ; Jenny P-Y Ting [États-Unis]The Innate Immune Receptor NLRX1 Functions as a Tumor Suppressor by Reducing Colon Tumorigenesis and Key Tumor-Promoting Signals.
001B17 (2016) Ebun Omoyinmi [Royaume-Uni] ; Raja Hamaoui [Royaume-Uni] ; Annette Bryant [Royaume-Uni] ; Mike Chao Jiang [Royaume-Uni] ; Trin Athigapanich [Royaume-Uni] ; Despina Eleftheriou [Royaume-Uni] ; Mike Hubank [Royaume-Uni] ; Paul Brogan [Royaume-Uni] ; Patricia Woo [Royaume-Uni]Mitochondrial and oxidative stress genes are differentially expressed in neutrophils of sJIA patients treated with tocilizumab: a pilot microarray study
001E88 (2015) Hiroki Goto [Japon] ; Eriko Kudo ; Ryusho Kariya ; Manabu Taura ; Harutaka Katano ; Seiji OkadaTargeting VEGF and interleukin-6 for controlling malignant effusion of primary effusion lymphoma.
001F99 (2015) Gian Luca Erre [Italie] ; Giuseppe Mameli [Italie] ; Davide Cossu [Italie] ; Benedetta Muzzeddu [Italie] ; Cristina Piras [Italie] ; Daniela Paccagnini [Italie] ; Giuseppe Passiu [Italie] ; Leonardo Antonio Sechi [Italie]Increased Epstein-Barr Virus DNA Load and Antibodies Against EBNA1 and EA in Sardinian Patients with Rheumatoid Arthritis.
002329 (2014) Yu Zheng [Australie] ; Dennis Basel ; Shu-Oi Chow ; Colette Fong-Yee ; Sarah Kim ; Frank Buttgereit ; Colin R. Dunstan ; Hong Zhou ; Markus J. SeibelTargeting IL-6 and RANKL signaling inhibits prostate cancer growth in bone.
002516 (2014) Sudipto Das [Royaume-Uni] ; Edward M. Vital ; Sarah Horton ; Domini Bryer ; Yasser El-Sherbiny ; Andrew C. Rawstron ; Frederique Ponchel ; Paul Emery ; Maya H. BuchAbatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Real-Time Polymerase Chain Reaction" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Real-Time Polymerase Chain Reaction" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Real-Time Polymerase Chain Reaction
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021